Provider use of preventive strategies for radiocontrast nephropathy in high-risk patients

Nephron - Clinical Practice

Volumn 96, Issue 2, 2004, Pages

  Weisbord, Steven D ^a,c   Bruns, Frank J ^a   Saul, Melissa I ^a   Palevsky, Paul M ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cyclo oxygenase inhibitors; Intravenous fluids; Nonsteroidal anti inflammatories; Radiocontrast nephropathy

Indexed keywords

CONTRAST MEDIUM; CYCLOOXYGENASE 2 INHIBITOR; INFUSION FLUID; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; FEMALE; HEALTH CARE PERSONNEL; HIGH RISK PATIENT; HUMAN; MALE; MEDICAL RECORD; NEPHROTOXICITY; PREVENTIVE HEALTH SERVICE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RADIOCONTRAST NEPHROPATHY; RANDOMIZATION; REVIEW; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CONTRAST MEDIA; CYCLOOXYGENASE INHIBITORS; FEMALE; FLUID THERAPY; HUMANS; KIDNEY FAILURE, ACUTE; MALE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; RISK FACTORS; WITHHOLDING TREATMENT;

EID: 1842474895     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076400     Document Type: Review

References (41)

1. Davidson CJ, Hlatky M, Morris KG et al: Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med 1989;110:119-124.
2. Parfrey PS, Griffiths SM, Barrett BJ et al: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989;320:143-149.
3. Deray G, Brillet G, Baumelou A, Jacobs C: Acute renal failure following coronary arteriography and ventriculography with ioxaglate, a low-osmolality radiocontrast agent. Am J Kidney Dis 1990;16:506-507.
4. Porter GA: Contrast-associated nephropathy. Am J Cardiol 1989;64:22E-26E.
5. Vari RC, Natarajan LA, Whitescarver SA, Jackson BA, Ott CE: Induction, prevention and mechanisms of contrast media-induced acute renal failure. Kidney Int 1988;33:699-707.
6. Lautin EM, Freeman NJ, Schoenfeld AH et al: Radiocontrast-associated renal dysfunction: Incidence and risk factors. AJR Am J Roentgenol 1991;157:49-58.
7. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW: Acute renal failure after coronary intervention: Incidence, risk factors and relationship to mortality. Am J Med 1997;103:368-375.
8. Rich MW, Crecelius CA: Incidence, risk factors and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 1990;150:1237-1242.
9. Taliercio CP, Vlietstra RE, Fisher LD, Burnett JC: Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986;104:501-504.
10. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275:1489-1494.
11. Aronow HD, Peyser PA, Eagle KA et al: Predictors of length of stay after coronary stenting. Am Heart J 2001;142:799-805.
12. Cacoub P, Deray G, Baumelou A, Jacobs C: No evidence for protective effects of nifedipine against radiocontrast-induced acute renal failure. Clin Nephrol 1988;29:215-216.
13. Kellum JA: The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence. Crit Care (Lond) 1997;1:53-59.
14. Cosentino F: Drugs for the prevention and treatment of acute renal failure. Cleve Clin J Med 1995;62:248-253.
15. Solomon R, Werner C, Mann D, D'Elia J, Silva P: Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-1420.
16. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W: Prevention of radiographic contrast agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-184.
17. Abizaid AS, Clark CE, Mintz GS et al: Effects of dopamine and aminophylline on contrastinduced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. Am J Cardiol 1999;83:260-263.
18. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M: Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000;11:97-104.
19. Kurnik BR, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS: Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 1998;31:674-680.
20. Shammas NW, Kapalis MJ, Harris M, McKinney D, Coyne EP: Aminophylline does not protect against radiocontrast nephropathy in patients undergoing percutaneous angiographic procedures. J Invasive Cardiol 2001;13:738-740.
21. Erley CM: Does hydration prevent radiocontrast-induced acute renal failure? Nephrol Dial Transplant 1999;14:1064-1066.
22. Eisenberg RL, Bank WO, Hedgock MW: Renal failure after major angiography can be avoided with hydration. AJR Am J Roentgenol 1981;136:859-861.
23. Kerstein MD, Puyau FA: Value of periangiography hydration. Surgery 1984;96:919-922.
24. Conger J: Hemodynamic factors in acute renal failure. Adv Ren Replace Ther 1997;4:25-37.
25. Ahmad SR, Kortepeter C, Brinker A, Chen M, Beitz J: Renal failure associated with the use of celecoxib and rofecoxib. Drug Saf 2002;25:537-544.
26. Workman RJ, Shaff MI, Jackson RV, Diggs J, Frazer MG, Briscoe C: Relationship of renal hemodynamic and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dog. Invest Radiol 1983;18:160-166.
27. Baker CS, Baker LR: Prevention of contrast nephropathy after cardiac catheterisation. Heart 2001:361-362.
28. Barrett BJ: Contrast nephrotoxicity. J Am Soc Nephrol 1994;5:125-137.
29. Bennett WM, Porter GA: Nephrotoxicity of common drugs used by urologists. Urol Clin North Am 1990;17:145-156.
30. Yount R, Vries J, Council C: The Medical Archival Retrieval System: An information retrieval system based on distributed parallel processing. Inf Process Manage 1991;27:1-11.
31. Iezzoni LI, Moskowitz MA: A clinical assessment of MedisGroups. JAMA 1988;260:3159-3163.
32. Levey AS GT, Kusek JW, Beck GJ: A simplified equation to predict glomerular filtration rate from serum creatinine (abstract). J Am Soc Nephrol 2000;11:A0828.
33. Heyman SN, Brezis M, Reubinoff CA et al: Acute renal failure with selective medullary injury in the rat. J Clin Invest 1988;82:401-412.
34. Yoshioka T, Fogo A, Beckman JK: Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int 1992;41:1008-1015.
35. Erley CM, Heyne N, Rossmeier S, Vogel T, Risler T, Osswald H: Adenosine and extracellular volume in radiocontrast media-induced nephropathy. Kidney Int Suppl 1998;67:S192-S194.
36. Anto HR, Chou SY, Porush JG, Shapiro WB: Infusion intravenous pyelography and renal function. Effect of hypertonic mannitol in patients with chronic renal insufficiency. Arch Intern Med 1981;141:1652-1656.
37. Mueller C, Buerkle G, Buettner HJ et al: Prevention of contrast media-associated nephropathy: Randomized comparison of two hydration regimens in 1,620 patients undergoing coronary angioplasty. Arch Intern Med 2002;162:329-336.
38. Trivedi HS, Moore H, Nasr S et al: A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron 2003;93:C29-C34.
39. National Quality Forum website: http://www. qualityforum.org/
40. Sheldon WC: Trends in cardiac catheterization laboratories in the United States. Catheter Cardiovasc Interv 2001;53:40-45.
41. Schneider EL, Guralnik JM: The aging of America. Impact on health care costs. JAMA 1990;263:2335-2340.